Boston Scientific, J&J Inundate Docs With DES Efficacy Data
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific and J&J/Cordis agree that physician selection among drug-eluting stents is being swayed by the amount of real-world clinical data each company possesses for its respective device